Tower Research Capital LLC (Trc) Evolus, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Evolus, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,503 shares of EOLS stock, worth $38,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,503

Previous 4,978 29.63%

Holding current value

$38,147

Previous $54,000 3.7%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.66 - $17.48 $15,723 - $25,783	-1,475 Reduced 29.63%	3,503 $56,000
Q2 2024 Aug 13, 2024	BUY	$10.45 - $13.76 $43,994 - $57,929	4,210 Added 548.18%	4,978 $54,000
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $90,988 - $135,800	-9,108 Reduced 92.22%	768 $10,000
Q4 2023 Feb 13, 2024	SELL	$7.6 - $10.53 $13,163 - $18,237	-1,732 Reduced 14.92%	9,876 $103,000
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $73,566 - $104,947	10,289 Added 780.06%	11,608 $106,000
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $2,595 - $3,776	359 Added 37.4%	1,319 $9,000
Q1 2023 May 09, 2023	SELL	$7.81 - $11.05 $190,329 - $269,288	-24,370 Reduced 96.21%	960 $8,000
Q4 2022 Feb 10, 2023	BUY	$6.52 - $8.95 $123,606 - $169,674	18,958 Added 297.52%	25,330 $191,000
Q3 2022 Nov 10, 2022	BUY	$7.76 - $13.72 $40,514 - $71,632	5,221 Added 453.61%	6,372 $51,000
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $31,549 - $43,032	-3,087 Reduced 72.84%	1,151 $14,000
Q1 2022 May 12, 2022	BUY	$5.22 - $11.78 $10,205 - $23,029	1,955 Added 85.63%	4,238 $48,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $78,536 - $122,557	-14,625 Reduced 86.5%	2,283 $15,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $114,852 - $213,320	15,605 Added 1197.62%	16,908 $128,000
Q2 2021 Aug 16, 2021	SELL	$8.42 - $13.96 $5,708 - $9,464	-678 Reduced 34.23%	1,303 $16,000
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $12,291 - $63,414	-3,841 Reduced 65.97%	1,981 $26,000
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $51,380 - $85,164	-17,596 Reduced 75.14%	5,822 $20,000
Q3 2020 Nov 16, 2020	BUY	$3.03 - $5.48 $50,310 - $90,989	16,604 Added 243.67%	23,418 $92,000
Q2 2020 Aug 13, 2020	BUY	$3.53 - $6.17 $24,053 - $42,042	6,814 New	6,814 $36,000
Q4 2019 Feb 07, 2020	SELL	$11.58 - $17.37 $4,585 - $6,878	-396 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$13.91 - $19.87 $9,236 - $13,193	-664 Reduced 62.64%	396 $6,000
Q2 2019 Aug 13, 2019	BUY	$13.19 - $28.36 $2,492 - $5,360	189 Added 21.7%	1,060 $15,000
Q1 2019 May 14, 2019	SELL	$12.43 - $28.91 $60,384 - $140,444	-4,858 Reduced 84.8%	871 $20,000
Q4 2018 Feb 14, 2019	BUY	$10.57 - $19.29 $60,555 - $110,512	5,729 New	5,729 $68,000
Q3 2018 Nov 13, 2018	SELL	$17.31 - $29.82 $113,467 - $195,470	-6,555 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$6.85 - $38.49 $39,688 - $223,011	5,794 Added 761.37%	6,555 $183,000
Q1 2018 May 15, 2018	BUY	$8.34 - $12.5 $6,346 - $9,512	761 New	761 $7,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Evolus, Inc. Transaction History